Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 10 | Mind Blowing Facts

Infected blood scandal victims 'harmed further' by compensation delays, scathing new report finds

Chairman of inquiry into scandal say just 460 people receiving compensation ‘profoundly unsatisfactory’ as he calls for ‘faster and fairer’ compensation for victims

Evening Standard

We have drugs to manage HIV. So why are we spending millions looking for cures?

Over the past three decades there have been amazing advances in treating and preventing HIV.

The Conversation

Bill Gates Warns US 'It's Not Too Late To Change Course' As Trump Team Targets HIV Funding Cuts

Billionaire philanthropist and co-founder of Microsoft Inc. (NASDAQ:MSFT) Bill Gates has responded to a video posted by Senator Susan Collins (R-ME) regarding the President’s Emergency Plan for AIDS Relief (PEPFAR).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump’s ‘Trans Mice’ Line Got Laughs. The Science Behind It Could Save Lives.

Research on HIV, cancer and infertility is being quietly dismantled under Trump’s anti-DEI agenda.

Capital & Main

Idaho doctor, patients sue over new law halting public benefits to immigrants in US unlawfully

A new Idaho law restricting public benefits for undocumented immigrants is facing a legal challenge

The Independent UK

HIV transmission in Papua New Guinea at crisis levels

Seven newborn babies are found to have HIV every day in Papua New Guinea despite the availability of preventative drugs.

AAP

HIV Patients at Risk as New Budget Plan Targets Critical Funding

As lawmakers in Washington debate the new federal budget, one group is bracing for devastating consequences: Americans living with HIV. The proposed GOP-led budget calls...

Saving Advice

Read news from The Economist, FT, and more,
with one subscription

US approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new treatment marks a major advancement in expanding prevention options for people at risk of HIV infection.

The Conversation

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the people who need it? Rachel Schraer reports

The Independent UK

Marjorie Taylor Greene Buys Stocks Focusing on Tech, Energy, and a Biotech Firm That Recently Received FDA Approval for HIV Drug

US Congress member Marjorie Taylor Greene purchased shares of Adobe, Netflix, Snowflake, ServiceNow, NextEra Energy, and Gilead Sciences on 6th June.

International Business Times UK

New preventative shot could ‘end HIV transmission’

IN FULL

The Independent UK

Groundbreaking single-dose vaccine found effective in preventing HIV

Strategy may lead to new vaccines that only need to be taken once

The Independent UK

Groundbreaking twice-a-year HIV drug that could stop transmission approved

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication

The Independent UK

US Approves Gilead's Twice-yearly Injection To Prevent HIV

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Here’s what to know about the twice-yearly preventative HIV shot

A twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP

The Independent UK

‘I’ve lost hope of overturning Uganda’s brutal anti-LGBT+ law thanks to Trump’s aid cuts’

IN FOCUS: Without US funding as leverage, one of Uganda’s most prominent LGBT+ activists Steven Kabuye tells Rachel Schraer, there are few ways to push the country towards change

The Conversation

Gay Men’s Health Crisis showed how everyday people stepped up when institutions failed during the height of the AIDS epidemic – providing a model for today

The story of the AIDS movement is one of regular people: students, bartenders, stay-at-home mothers, teachers, retired lawyers, immigrants, Catholic nuns, newly out gay men who had just arrived in New York, and many others. Some had lost friends or lovers. Some felt a moral calling. Some were just trying…

The Independent UK

Australia makes world-first change to blood donation rules

IN FULL

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Australia lifts ban preventing gay men from donating blood and plasma

Lifeblood will no longer ask men if they had sex with men in the past three months

The Conversation

Gay and bisexual men will soon be able to donate blood and plasma

Many gay and bisexual men have been excluded from donating blood and plasma (the liquid portion of blood) for decades because of rules developed during the HIV crisis in the 1980s.

The Guardian - AU

Ban on gay and bisexual men donating blood and plasma in Australia to be scrapped

Lifeblood heralds ‘world-leading plasma pathway’ amid change to HIV-era restrictions

The Conversation

When developing countries band together, lifesaving drugs become cheaper and easier to buy − with trade-offs

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often neither available nor affordable in these nations, even decades after the drugs entered the market.

The Independent UK

Congress should be ashamed over helping Trump cut foreign aid, activists say

Campaigners say the US government has been withholding funds for orphans and vulnerable children unlawfully – before a vote in Congress has backed Trump’s move

The Guardian - UK

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

The Guardian - UK

South Africa is at the heart of the HIV pandemic. What happens now the money has been cut?

With 12% of the population living with the virus, Trump’s sudden withdrawal of funding stands to undo decades of progress

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the House of Representatives

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.